NCT01933373

Brief Summary

Achalasia is a rare motor disorder of the gastroesophageal junction which is associated with an increased pressure of the esophageal sphincter. This leads to impairment to swallow and heartburn. Esophageal myotomy, which is a surgical longitudinal incision of the esophageal muscle layer extending over to the gastroesophageal junction is the treatment of choice for achalasia. In order to prevent reflux of stomach content into the esophagus this has to be combined with an antireflux procedure where the upper part of the stomach (fundus) is wrapped around the esophagus (fundoplication). This procedure can be performed with the wrapped fundus either in front of the esophagus (Dor procedure) or behind (Toupet). The latter introduces an angulation of the esophagus, which possibly may lead to an impairment of swallowing ability and passage of food to the stomach. On the other hand, the Toupet procedure may give a better control of reflux. The primary endpoint of the study is symptoms of impaired swallowing 1 year after treatment. Secondary outcomes include reflux (pH measurements in the esophagus), radiological imaging of swallowing and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 19, 2013

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 2, 2013

Completed
Last Updated

September 2, 2013

Status Verified

August 1, 2013

Enrollment Period

4.6 years

First QC Date

June 19, 2013

Last Update Submit

August 30, 2013

Conditions

Keywords

RandomizedToupetDorAchalasia

Outcome Measures

Primary Outcomes (1)

  • Dysphagia symptoms according to Eckhardt

    up to five years follow up

Secondary Outcomes (3)

  • Ambulatory esophageal PH

    One and five years follow up

  • Health-related quality of life according to Velanovich

    One and five years follow up

  • Timed barium esophagogram at 1, 2 and 5 minutes

    One and five years follow up

Study Arms (2)

Toupet

ACTIVE COMPARATOR

Laparoscopic Myotomy + Toupet 180 degree partial posterior fundoplication.

Procedure: Toupet

Dor

EXPERIMENTAL

Laparoscopic Myotomy + Dor anterior partial fundoplication. 90 degree partial fundoplication being the standard of care.

Procedure: Dor

Interventions

ToupetPROCEDURE

Laparoscopic posterior partial fundoplication plus myotomy.

Also known as: Laparascopic posterior partial fundoplication plus myotomy.
Toupet
DorPROCEDURE

Anterior partial fundoplication plus myotomy.

Also known as: Anterior partial fundoplication plus myotomy.
Dor

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>18 years of age
  • Typical achalasia according to manometry
  • Eckhardt score \>3
  • Informed consent

You may not qualify if:

  • Severe comorbidity precluding surgery
  • Pseudo achalasia
  • Inability to participate in follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska University Hospital

Stockholm, 14186, Sweden

Location

Related Publications (1)

  • Kumagai K, Kjellin A, Tsai JA, Thorell A, Granqvist S, Lundell L, Hakanson B. Toupet versus Dor as a procedure to prevent reflux after cardiomyotomy for achalasia: results of a randomised clinical trial. Int J Surg. 2014;12(7):673-80. doi: 10.1016/j.ijsu.2014.05.077. Epub 2014 Jun 2.

MeSH Terms

Conditions

Esophageal Achalasia

Interventions

MyotomyReceptors, Opioid, delta

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, OperativeReceptors, OpioidReceptors, G-Protein-CoupledReceptors, Cell SurfaceMembrane ProteinsProteinsAmino Acids, Peptides, and ProteinsReceptors, NeuropeptideReceptors, NeurotransmitterReceptors, Peptide

Study Officials

  • Lars R Lundell, Professor

    Gastrocentrum Karolinska University Hospital, Stockholm Sweden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 19, 2013

First Posted

September 2, 2013

Study Start

May 1, 2007

Primary Completion

December 1, 2011

Study Completion

December 1, 2012

Last Updated

September 2, 2013

Record last verified: 2013-08

Locations